Miositis por estatinas

Referencias:

- https://www.msdmanuals.com/es-ec/professional/trastornos-de-los-tejidos-musculoesquel%C3%A9tico-y-conectivo/enfermedades-reum%C3%A1ticas-autoinmumunitarias/miositis-autoinmune
- Bertorini, Tulio, Meza, Kelly, & Chunga, Natalia. (2019). Miopatías autoinmunes: revisión de diagnóstico y manejo. Anales de la Facultad de Medicina, 80(3), 362-371. https://dx.doi.org/10.15381/anales.803.16274
- https://www.intramed.net/contenidover.asp?contenidoid=87215&pagina=2
- Mohassel, P., & Mammen, A. L. (2018). Anti-HMGCR Myopathy. Journal of neuromuscular diseases, 5(1), 11-20.
- Mohassel, P. et al. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies. Muscle & Nerve 2013; 48: 477-483.
- Mammen, A. Statin-associated autoimmune myopathy. N Engl J Med. 2016; 374: 664-669.
- Musset, L. et al. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study. Autoimmunity Reviews. 2016; 15: 983-993.
- Dobbels, L. et al. A 62 year old woman with muscle weakness. Clinical Chemistry 2015; 61:9 1133-1137.
- Kishi T, et al Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies are Associated with DRB1*07:01 and Severe Myositis in Pediatric Myositis Patients. Arthriitis Care Res. 2017 69(7):1088-94.
- Mammen A, et al Increased Frequency of DRB1*11:01 inAnti–Hydroxymethylglutaryl-Coenzyme AReductase–Associated Autoimmune Myopathy. Arthritis Care Res. 2012 64(8): 1233-7.
- National Clinical Guideline Centre (UK). July 2014. PMID 25340243
- Klein M et al. Increasing incidence of immune mediated necrotizing myopathy in a single center. Rheumatology 2015